About ICU Medical (NASDAQ:ICUI)
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
Trailing P/E Ratio55.78
Forward P/E Ratio46.23
Sales & Book Value
Annual Sales$1.29 billion
Price / Sales4.84
Cash Flow$9.0346 per share
Price / Cash34.08
Book Value$59.52 per share
Price / Book5.17
EPS (Most Recent Fiscal Year)$5.52
Net Income$68.64 million
Return on Equity9.55%
Return on Assets7.47%
ICU Medical (NASDAQ:ICUI) Frequently Asked Questions
What is ICU Medical's stock symbol?
ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."
How were ICU Medical's earnings last quarter?
ICU Medical, Incorporated (NASDAQ:ICUI) issued its earnings results on Wednesday, May, 9th. The medical instruments supplier reported $2.26 EPS for the quarter, topping the consensus estimate of $1.84 by $0.42. The medical instruments supplier had revenue of $372 million for the quarter, compared to analyst estimates of $346.28 million. ICU Medical had a net margin of 1.25% and a return on equity of 9.55%. The business's revenue was up 50.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.68 EPS. View ICU Medical's Earnings History.
When is ICU Medical's next earnings date?
Who are some of ICU Medical's key competitors?
Some companies that are related to ICU Medical include ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), Insulet (PODD), Globus Medical (GMED), Penumbra (PEN), Haemonetics (HAE), Cantel Medical (CMD), NuVasive (NUVA), Novocure (NVCR), Merit Medical Systems (MMSI), Nevro (NVRO) and Irhythm Technologies (IRTC).
Who are ICU Medical's key executives?
ICU Medical's management team includes the folowing people:
- Mr. Vivek Jain, Chairman & CEO (Age 46)
- Mr. Scott E. Lamb, CFO & Treasurer (Age 55)
- Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 60)
- Ms. Alison D. Burcar, Corp. VP of Product Strategy for IV Consumables (Age 45)
- Mr. Steven C. Riggs, Exec. Officer of Special Project Opertions (Age 59)
Has ICU Medical been receiving favorable news coverage?
Media stories about ICUI stock have trended positive this week, according to Accern Sentiment. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. ICU Medical earned a media sentiment score of 0.27 on Accern's scale. They also assigned headlines about the medical instruments supplier an impact score of 47.97 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are ICU Medical's major shareholders?
ICU Medical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.10%), Millennium Management LLC (2.70%), JPMorgan Chase & Co. (2.33%), GW&K Investment Management LLC (2.27%), Wells Fargo & Company MN (2.25%) and Silvercrest Asset Management Group LLC (1.77%). Company insiders that own ICU Medical stock include Alison D Burcar, Daniel Woolson, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Richard Md Sherman, Robert S Swinney, Scott E Lamb, Steven Riggs, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical.
Which institutional investors are selling ICU Medical stock?
ICUI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Champlain Investment Partners LLC, Principal Financial Group Inc., Principal Financial Group Inc., Citadel Advisors LLC, Silvercrest Asset Management Group LLC, WINTON GROUP Ltd and Eagle Asset Management Inc.. Company insiders that have sold ICU Medical company stock in the last year include Daniel Woolson, George A Lopez, Joseph R Saucedo, Robert S Swinney, Scott E Lamb, Virginia Ruth Sanzone and Vivek Jain. View Insider Buying and Selling for ICU Medical.
Which institutional investors are buying ICU Medical stock?
ICUI stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Redmile Group LLC, Northern Trust Corp, Carillon Tower Advisers Inc., Millennium Management LLC, JPMorgan Chase & Co., Guggenheim Capital LLC and American International Group Inc.. View Insider Buying and Selling for ICU Medical.
How do I buy shares of ICU Medical?
Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is ICU Medical's stock price today?
One share of ICUI stock can currently be purchased for approximately $307.90.
How big of a company is ICU Medical?
ICU Medical has a market capitalization of $6.26 billion and generates $1.29 billion in revenue each year. The medical instruments supplier earns $68.64 million in net income (profit) each year or $5.52 on an earnings per share basis. ICU Medical employs 6,802 workers across the globe.
How can I contact ICU Medical?
ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92673. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]
MarketBeat Community Rating for ICU Medical (ICUI)MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.